Perioperative nivolumab did not improve RFS in RCC patients at high risk for recurrence
Perioperative nivolumab did not improve RFS in RCC patients at high risk for recurrence
Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressing desmoid tumours
Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma
Olaparib continues to show positive results in advanced ovarian cancer - 7 year data
Nirogacestat success for desmoid tumours
WCLC 2022: Highlights
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
An overview of treatment advances in gastric cancer
Optimum treatment strategy algorithm for mCRC
Bladder cancer: Current state and future directions in treatment
Optimum treatment algorithm in management of advanced prostate cancer